BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/16/2024 8:03:14 AM | Browse: 89 | Download: 231
 |
Received |
|
2024-06-23 13:31 |
|
Peer-Review Started |
|
2024-06-23 13:31 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-07-09 12:53 |
|
Revised |
|
2024-07-18 12:57 |
|
Second Decision |
|
2024-07-24 02:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-07-24 08:03 |
|
Articles in Press |
|
2024-07-24 08:03 |
|
Publication Fee Transferred |
|
2024-07-28 12:50 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-08-12 07:33 |
|
Publish the Manuscript Online |
|
2024-08-16 08:03 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Effect and safety of ripretinib in the treatment of advanced gastrointestinal stromal tumor: A systematic review and meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ji Li, Hao Zhang and Xiao-Dong Chen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Xiao-Dong Chen, MS, Doctor, Doctor, Master's Student, Department of General Surgery, Chongqing Western Hospital, No. 301 Huafu Road, Jiulongpo, Chongqing 400051, China. 236165437@qq.com |
| Key Words |
Gastrointestinal stromal tumor; Ripretinib; PDGFRA; KIT; Meta-analysis |
| Core Tip |
The current therapeutic drugs have limited effectiveness in treating secondary mutations in different gastrointestinal stromal tumor (GIST), and new treatment strategies need to be developed. Ripretinib (RPT) is a new, switch-control tyrosine kinase inhibitors that can suppress different mutations of KIT and PDGFRA via a dual mechanism of action. This study aims to investigate the literature on RPT to assess an effective, safe, and successful treatment strategy against advanced GIST. |
| Publish Date |
2024-08-16 08:03 |
| Citation |
<p>Li J, Zhang H, Chen XD. Effect and safety of ripretinib in the treatment of advanced gastrointestinal stromal tumor: A systematic review and meta-analysis. <i>World J Clin Oncol</i> 2024; 15(8): 1092-1101</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v15/i8/1092.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v15.i8.1092 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
